|
RAB5C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.58489998692124E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.55179996314581E-09 |
| Normal-vs-Stage2 |
7.908300E-02 |
| Normal-vs-Stage3 |
7.604500E-03 |
| Normal-vs-Stage4 |
2.43739999999937E-05 |
| Stage1-vs-Stage2 |
2.733200E-01 |
| Stage1-vs-Stage3 |
3.579600E-01 |
| Stage1-vs-Stage4 |
6.199000E-01 |
| Stage2-vs-Stage3 |
8.024400E-01 |
| Stage2-vs-Stage4 |
2.812200E-01 |
| Stage3-vs-Stage4 |
2.943000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.12719999579537E-09 |
| Normal-vs-AfricanAmerican |
6.76129999765962E-08 |
| Normal-vs-Asian |
4.424000E-01 |
| Caucasian-vs-AfricanAmerican |
6.490200E-01 |
| Caucasian-vs-Asian |
6.293400E-01 |
| AfricanAmerican-vs-Asian |
6.853400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55260035331162E-10 |
| Normal-vs-Female |
4.376600E-03 |
| Male-vs-Female |
5.357000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.51256999999516E-05 |
| Normal-vs-Extreme_Weight |
1.32489996751417E-09 |
| Normal-vs-Obese |
8.78619999977737E-07 |
| Normal-vs-Extreme_Obese |
1.259560E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.890000E-01 |
| Normal_Weight-vs-Obese |
4.826000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.785600E-01 |
| Extreme_Weight-vs-Obese |
1.950570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.026000E-01 |
| Obese-vs-Extreme_Obese |
8.040800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.112000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.55059999998419E-06 |
| Normal-vs-Age(61-80Yrs) |
1.01319996836935E-09 |
| Normal-vs-Age(81-100Yrs) |
4.09100000542395E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.563640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.052100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.540100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.480300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.407900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.932190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17740003805034E-09 |
| Normal-VS-Type2 PRCC |
1.382060E-04 |
| Normal-VS-KIRP CIMP |
6.525500E-02 |
| Normal-VS-Unclassified PRCC |
6.528000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.324200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.421800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.947900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.495400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.643600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.435000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.8019999999972E-05 |
| Normal-vs-N1 |
4.217600E-04 |
| Normal-vs-N2 |
4.196600E-01 |
| N0-vs-N1 |
9.786200E-01 |
| N0-vs-N2 |
6.586200E-01 |
| N1-vs-N2 |
6.192000E-01 |
|
|
